ReViral is formerly owned by Andera Partners, through BioDiscovery 4, since 2015.

When did Andera Partners acquire ReViral?

Andera Partners acquired ReViral in 2015 and exited after 7 years.

Has ReViral been sold?

Yes. ReViral was exited in 2022 via Trade Sale.

Healthcare·

UK·Exited 2022·Held 7yr

ReViral is a healthcare company, headquartered in United Kingdom.

Entry

2015

Hold

7yr

Exit

2022

Est. EV

–

Investor

HQUnited Kingdom

SectorHealthcare

Small molecules as a therapeutic treatment for RSV infection

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in BioDiscovery 4

6 comparable healthcare deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings